1. Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model.
- Author
-
Generoso SV, Viana M, Santos R, Martins FS, Machado JA, Arantes RM, Nicoli JR, Correia MI, and Cardoso VN
- Subjects
- Animals, Escherichia coli physiology, Immunoglobulin A, Secretory analysis, Interleukin-10 blood, Intestinal Mucosa immunology, Intestinal Mucosa pathology, Intestinal Mucosa physiopathology, Intestinal Obstruction immunology, Intestinal Obstruction microbiology, Intestinal Obstruction pathology, Intestines immunology, Intestines microbiology, Intestines pathology, Liver microbiology, Liver pathology, Lung microbiology, Lung pathology, Lymph Nodes microbiology, Lymph Nodes pathology, Male, Mice, Microbial Viability, Permeability, Probiotics administration & dosage, Spleen microbiology, Spleen pathology, Technetium Tc 99m Pentetate, Bacterial Translocation, Immunomodulation, Intestinal Obstruction therapy, Intestines physiopathology, Probiotics therapeutic use, Saccharomyces cerevisiae physiology
- Abstract
Probiotic is a preparation containing microorganisms that confers beneficial effect to the host. This work assessed whether oral treatment with viable or heat-killed yeast Saccharomyces cerevisiae strain UFMG 905 prevents bacterial translocation (BT), intestinal barrier integrity, and stimulates the immunity, in a murine intestinal obstruction (IO) model. Four groups of mice were used: mice undergoing only laparotomy (CTL), undergoing intestinal obstruction (IO) and undergoing intestinal obstruction after previous treatment with viable or heat-killed yeast. BT, determined as uptake of (99m)Tc-E. coli in blood, mesenteric lymph nodes, liver, spleen and lungs, was significantly higher in IO group than in CTL group. Treatments with both yeasts reduced BT in blood and all organs investigated. The treatment with both yeasts also reduced intestinal permeability as determined by blood uptake of (99m)Tc-DTPA. Immunological data demonstrated that both treatments were able to significantly increase IL-10 levels, but only viable yeast had the same effect on sIgA levels. Intestinal lesions were more severe in IO group when compared to CTL and yeasts groups. Concluding, both viable and heat-killed cells of yeast prevent BT, probably by immunomodulation and by maintaining gut barrier integrity. Only the stimulation of IgA production seems to depend on the yeast viability.
- Published
- 2010
- Full Text
- View/download PDF